N@N

Brian Cheng Maintained (APLS) at Hold with Increased Target to $43 on, Sep 8th, 2023

Brian Cheng of B of A Securities, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Increased Target from $40 to $43 on, Sep 8th, 2023.

Brian has made no other calls on APLS in the last 4 months.

There are 11 other peers that have a rating on APLS. Out of the 11 peers that are also analyzing APLS, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $29 on, Wednesday, August 23rd, 2023
• Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $60 on, Thursday, August 3rd, 2023
• Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $53 on, Thursday, July 20th, 2023

These are the ratings of the 8 analyists that currently disagree with Brian

---

• Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $60 on, Wednesday, August 30th, 2023
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $54 on, Wednesday, August 30th, 2023
• Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Tuesday, August 29th, 2023
• Justin Kim of "Oppenheimer" Reiterated at Buy on, Wednesday, August 23rd, 2023
• Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $82 on, Wednesday, August 23rd, 2023
• Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $64 on, Wednesday, August 23rd, 2023
• Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $70 on, Tuesday, August 1st, 2023
• Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $89 on, Tuesday, August 1st, 2023

Contributing Sources

---